Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Brian Maurer"'
Publikováno v:
Airway pharmacology and treatment.
Ensifentrine (RPL554) is an investigational, first-in-class, inhaled dual inhibitor of the enzymes PDE 3 and 4 that combines bronchodilator and anti-inflammatory actions in a single compound. In previous trials, nebulised ensifentrine delivered clini
Publikováno v:
Environmental Earth Sciences. 77
This study adapted the bulk fluorescein diacetate (FDA) assay to evaluate the impact of crude oil on biological activity levels in marine sediments. Sediment cores from the Elkhorn Slough, California were incubated with different levels of sweet crud
Publikováno v:
Chest. 156:A450-A451
Autor:
John Cahill, Enda Ryan, Lorna Timmons, Mary Ryder, Brian Maurer, Bronagh Travers, Kenneth McDonald, Mark Ledwidge, Michael J. Barry
Publikováno v:
European Journal of Heart Failure. 5:381-389
Background: Multidisciplinary care (MDC) of heart failure (HF) can significantly reduce rates of unplanned hospitalisation, the major cost component of HF care. Aims: This prospective, randomised, controlled study examines the cost-benefits of MDC of
Autor:
Lorna Timmons, Emma Kieran, John Cahill, Bronagh Travers, Enda Ryan, Ken McDonald, Brian Maurer, P. Quigley, Mary Ryder, Mark Ledwidge
Publikováno v:
Journal of Cardiac Failure. 8:142-148
Purpose: This work addresses the unanswered question of whether multidisciplinary care (MDC) of heart failure (HF) can reduce readmissions when optimal medical care is applied in both intervention and control groups. Methods: In a randomized, control
Publikováno v:
New England Journal of Medicine. 356:2653-2655
Autor:
Gary T. Ferguson, Ludmyla Rekeda, Paul D. Scanlon, Cynthia Caracta, Stephen I. Rennard, Brian Maurer, Esther Garcia Gil
Publikováno v:
Clinical drug investigation. 33(12)
Aclidinium bromide is a long-acting muscarinic antagonist approved for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD). This 12-week phase III study evaluated efficacy and tolerability
Autor:
Charles J. McCreery, Frances O'Sullivan, Alan K. Keenan, Gerard J. Fahy, Brian Maurer, P. Quigley
Publikováno v:
International Journal of Cardiology. 55:149-155
Study objectives. To determine if plasma levels of atrial natriuretic peptide are elevated in patients with hypertrophic cardiomyopathy and to determine the relationship of atrial natriuretic peptide to symptoms and echocardiographic indices of left
Autor:
Edward Kerwin, Cynthia Caracta, Barry J. Make, Anthony D'Urzo, Brian Maurer, Maria Teresa Sanz, Ludmyla Rekeda
Publikováno v:
A45. BRONCHODILATORS FOR COPD: OLD FAITHFULS AND NOVEL COMPOUNDS.
Autor:
Brian Maurer, James J. Crowley, Maire Tobin, Oliver FitzGerald, P. Quigley, Sinead M. Donnelly, Barry Bresnihan
Publikováno v:
The American Journal of Cardiology. 71:1337-1340
Although cardiac involvement in the form of conduction abnormalities or aortic regurgitation occurs in 5 to 10% of patients with ankylosing spondylitis, few studies have assessed left ventricular (LV) function. This study assesses the prevalence of b